Pricing Log in Create free account
Friday 6 November 2026 Export ABBV’s income statement to Excel — free account

AbbVie Inc.

ABBV Healthcare Drug Manufacturers General

AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.

Revenue
+10.3%
EPS
+2,270.0%
Free cash flow
+9.97%
Total debt
+17.7%

Quarter to September 2026, against a year earlier

290.81 2.57 +0.89%
Market cap
$509.5B
P/E
49.7×
Fwd P/E
38.6×
Dividend yield
2.40%
F-score
8/9
Altman Z
2.31
Beneish M
−2.86
Dividend safety
44/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

AbbVie Inc. (ABBV) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, AbbVie Inc. (ABBV) trades at a EV/Sales of 8.8×. Over the past ten years it has ranged from 3.7× (March 2020) to 9.0× (October 2026); the current reading is higher than 100% of that period. That is above the Drug Manufacturers General industry median of 4.1× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.6× 14.29%
FY2024 6.7× 10.13%
FY2023 6.1× 2.97%
FY2022 5.9× 7.89%
FY2021 5.5× (2.49%)
FY2020 5.6× 17.82%
FY2019 4.7× (10.80%)
FY2018 5.3× (18.67%)
FY2017 6.5× 27.44%
FY2016 5.1× (1.80%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 8.1× 2.03%
Jun 2026 7.9× 10.83%
Mar 2026 7.1× (6.41%)
Dec 2025 7.6× (3.76%)
43 more quarters

Against its own ten years

Low 3.7× High 9.0×
Ten-year median 5.6×
Current reading's percentile 100

EV/Sales against peers

Company EV/Sales
PFE Pfizer Inc. compare 3.4×
AZN AstraZeneca PLC compare 5.0×
NVS Novartis AG compare 6.0×
MRK Merck & Co., Inc. compare 6.0×
JNJ Johnson & Johnson compare 6.8×
GILD Gilead Sciences, Inc. compare 7.4×
AMGN Amgen Inc. compare 7.5×
ABBV AbbVie Inc. 8.8×
LLY Eli Lilly and Company compare 14.7×
Drug Manufacturers General industry median 4.1×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ABBV